291 related articles for article (PubMed ID: 27696293)
1. Reversion-inducing cysteine-rich protein with Kazal motifs and its regulation by glycogen synthase kinase 3 signaling in oral cancer.
Pramanik KK; Singh AK; Alam M; Kashyap T; Mishra P; Panda AK; Dey RK; Rana A; Nagini S; Mishra R
Tumour Biol; 2016 Nov; 37(11):15253-15264. PubMed ID: 27696293
[TBL] [Abstract][Full Text] [Related]
2. Glycogen synthase kinase-3β mediated regulation of matrix metalloproteinase-9 and its involvement in oral squamous cell carcinoma progression and invasion.
Pramanik KK; Nagini S; Singh AK; Mishra P; Kashyap T; Nath N; Alam M; Rana A; Mishra R
Cell Oncol (Dordr); 2018 Feb; 41(1):47-60. PubMed ID: 29134466
[TBL] [Abstract][Full Text] [Related]
3. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
[TBL] [Abstract][Full Text] [Related]
4. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
Zhang H; Zhang J; Nan X; Li X; Qu J; Hong Y; Sun L; Chen Y; Li T
Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation of the cysteine protease RECK may cause metastasis of osteosarcoma.
Wang L; Ge J; Ma T; Zheng Y; Lv S; Li Y; Liu S
Tumour Biol; 2015 Dec; 36(12):9511-6. PubMed ID: 26130413
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of the RECK gene predicts poor prognosis in oral squamous cell carcinomas.
Long NK; Kato K; Yamashita T; Makita H; Toida M; Hatakeyama D; Hara A; Mori H; Shibata T
Oral Oncol; 2008 Nov; 44(11):1052-8. PubMed ID: 18485791
[TBL] [Abstract][Full Text] [Related]
7. Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer.
Yu L; Li X; Li H; Chen H; Liu H
Tumour Biol; 2016 Oct; 37(10):13821-13829. PubMed ID: 27481517
[TBL] [Abstract][Full Text] [Related]
8. Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells.
Kato K; Long NK; Makita H; Toida M; Yamashita T; Hatakeyama D; Hara A; Mori H; Shibata T
Br J Cancer; 2008 Aug; 99(4):647-54. PubMed ID: 18665171
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor HBP1 is a direct anti-cancer target of transcription factor FOXO1 in invasive oral cancer.
Chan CY; Huang SY; Sheu JJ; Roth MM; Chou IT; Lien CH; Lee MF; Huang CY
Oncotarget; 2017 Feb; 8(9):14537-14548. PubMed ID: 28099936
[TBL] [Abstract][Full Text] [Related]
10. Expression of reversion-inducing cysteine-rich protein with kazal motifs and matrix metalloproteinase 9 in middle ear squamous cell carcinoma.
Liu X; Wang W; Chen J; Chen C; Zhou J; Cao L
ORL J Otorhinolaryngol Relat Spec; 2012; 74(1):16-21. PubMed ID: 22178867
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-15a promotes neuroblastoma migration by targeting reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and regulating matrix metalloproteinase-9 expression.
Xin C; Buhe B; Hongting L; Chuanmin Y; Xiwei H; Hong Z; Lulu H; Qian D; Renjie W
FEBS J; 2013 Feb; 280(3):855-66. PubMed ID: 23176145
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer.
Chang HC; Cho CY; Hung WC
Cancer Sci; 2007 Feb; 98(2):169-73. PubMed ID: 17233834
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of RECK in pathological outcome-dependent buccal mucosa squamous cell carcinoma.
Chen HC; Tseng YK; Shu CW; Fu TY; Liou HH; Huang CH; Chen CC; Wang JS; Wu PC; Ger LP; Hung WC; Liu PF
Oral Dis; 2020 Jan; 26(1):62-71. PubMed ID: 31618798
[TBL] [Abstract][Full Text] [Related]
14. Expression and inactivation of glycogen synthase kinase 3 alpha/ beta and their association with the expression of cyclin D1 and p53 in oral squamous cell carcinoma progression.
Mishra R; Nagini S; Rana A
Mol Cancer; 2015 Feb; 14():20. PubMed ID: 25645517
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter.
Lee KJ; Lee KY; Lee YM
Biochim Biophys Acta; 2010 May; 1803(5):608-16. PubMed ID: 20080132
[TBL] [Abstract][Full Text] [Related]
16. Reversion-inducing-cysteine-rich protein with Kazal motif is involved in intimal hyperplasia in carotid arteries: a new insight in the prevention of restenosis after vascular angioplasty.
Liu J; Chi D; Lu H; Zhang T; Yamakawa T
Ann Vasc Surg; 2015 Aug; 29(6):1293-9. PubMed ID: 26004948
[TBL] [Abstract][Full Text] [Related]
17. Effects of 5-aza-2'deoxycytidine on RECK gene expression and tumor invasion in salivary adenoid cystic carcinoma.
Zhou XQ; Huang SY; Zhang DS; Zhang SZ; Li WG; Chen ZW; Wu HW
Braz J Med Biol Res; 2015 Mar; 48(3):254-60. PubMed ID: 25517920
[TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin‑3‑gallate inhibits the invasion of salivary adenoid cystic carcinoma cells by reversing the hypermethylation status of the RECK gene.
Zhou XQ; Xu XN; Li L; Ma JJ; Zhen EM; Han CB
Mol Med Rep; 2015 Oct; 12(4):6031-6. PubMed ID: 26299812
[TBL] [Abstract][Full Text] [Related]
19. The elevated activation of NFκB and AP-1 is correlated with differential regulation of Bcl-2 and associated with oral squamous cell carcinoma progression and resistance.
Alam M; Kashyap T; Pramanik KK; Singh AK; Nagini S; Mishra R
Clin Oral Investig; 2017 Dec; 21(9):2721-2731. PubMed ID: 28233171
[TBL] [Abstract][Full Text] [Related]
20. microRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs.
Pan Y; Liang H; Chen W; Zhang H; Wang N; Wang F; Zhang S; Liu Y; Zhao C; Yan X; Zhang J; Zhang CY; Gu H; Zen K; Chen X
RNA Biol; 2015; 12(3):276-89. PubMed ID: 25826661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
